MARKETS / NYSE / CHE

NYSE · SERVICES-HOME HEALTH CARE SERVICES · LARGE CAP

Chemed Corp. CHE

18 fiscal years on record · USD · FY2025 reported · SEC filings only

17 YEARS OF DIVIDEND GROWTH

Revenue

$2.5B

▲ 4.1% YoY

Net income

$265.2M

▼ 12.2% YoY

Free cash flow

$325.5M

▼ 11.5% YoY

In brief

What this company does

Chemed Corporation operates through two segments, VITAS, which provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers, and Roto-Rooter, which provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. As of December 31, 2025, the Company, including its subsidiaries Roto-Rooter and VITAS, had a total of 15,811 employees. Over 90% of VITAS' revenue is from the United States government through the Medicare program. A significant portion of VITAS' business is operated in the state of Florida. Chemed Corporation was incorporated in Delaware in 1970 as a subsidiary of W.R. Grace & Co., and succeeded to the business of W.R. Grace & Co.'s Special Products Group as of April 30, 1971, remaining a subsidiary of W.R. Grace & Co. until March 10, 1982.

Written from the business description in CHEMED CORP's annual report to the U.S. Securities and Exchange Commission, filed 27 February 2026. Every sentence was checked against that document before publication.

Growth

USD 2.5B

Revenue, FY2025 · full 18-year series below

Revenue $B Net income $B

FY2025 · Revenue 2.5 · Net income 0.3

Compound annual growth

Revenue

+28.2%

+13.6%

+5.1%

+4.6%

Net income

+2.0%

−3.7%

+9.2%

+8.2%

EPS, diluted

+3.5%

−1.2%

+11.2%

+11.6%

Dividend / share

+14.1%

+10.8%

+9.1%

+10.1%

Returned to shareholders

+68.2%

+24.4%

+22.0%

+9.2%

3 yrs

5 yrs

10 yrs

15 yrs

Revenue compounded at +13.6% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

10 cents

of every revenue dollar became profit

Operating margin Net margin

FY2025 · Operating 13.4% · Net 10.5%

ROE

FY2025 · ROE 25.3%

Gross margin32.5%

Operating margin13.4%

Net margin10.5%

Return on assets16.5%

EBITDAUSD 403.1M

Each USD of equity produced 25 cents of profit this year.

Cash & shareholders

USD 436.0M

returned in FY2025 · dividends + net buybacks

Free cash flow $M

FY2025 · FCF 325.5

Net buybacks $M Dividends $M

FY2025 · Dividends 31.7 · Net buybacks 404.3

Dividends paidUSD 31.7M

Net buybacksUSD 404.3M

Share of profit164.4%

Consecutive raises17 years

USD 31.7M in dividends and USD 404.3M in buybacks — 164% of the year's profit, so the payout drew on cash built up earlier.

Total assetsUSD 1.5B

EquityUSD 979.4M

CashUSD 74.5M

Current ratio1.05×

Equity funds 64% of total assets.

The 18-year record

18 fiscal years

Every figure from documents filed with the SEC · USD

row low → row highnegative

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
Revenue $B	2.5	2.4	2.3	1.2	1.3	1.3	1.3	1.2	1.7	1.6	1.5	1.5	1.4	1.4	1.4	1.3	1.2	1.1
Operating income $B	0.3	0.4	0.3	0.3	0.3	0.4	0.3	0.2	0.1	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.1	0.1
EBITDA $B	0.4	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2
Income tax $B	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0
Net income $B	0.3	0.3	0.3	0.2	0.3	0.3	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Free cash flow $B	0.3	0.4	0.3	0.3	0.2	0.4	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
EPS, diluted $	18.34	19.89	17.93	16.53	16.85	19.48	13.31	12.23	5.86	6.48	6.33	5.57	4.16	4.62	4.10	3.55	3.24	2.88
Dividend / sh $	2.20	1.80	1.56	1.48	1.40	1.32	1.24	1.16	1.08	1.00	0.92	0.84	0.76	0.68	0.60	0.52	0.36	0.24
Payout %	12	9	9	9	8	7	9	9	18	15	14	14	18	15	15	15	11	8
ROE %	25.3	27.1	28.6	35.1	35.2	39.3	33.4	36.3	18.4	21.0	22.9	22.1	17.1	20.6	19.6	17.4	15.5	·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance

Company facts, as filed

How we verify · 0 failures in 70 reconciliationsAUDITED

Reconciled in 18 of 19 fiscal years. 7 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures

ActivityServices-Home Health Care Services

Listed onNYSE

Incorporated inDelaware

Fiscal year endsDecember 31

Data on record since2008